Abstract
We have investigated the interaction of oligonucleotides and their alkylating derivatives with mammalian cells. In experiments with L929 mouse fibroblast and Krebs 2 ascites carcinoma cells, it was found that cellular uptake of oligodeoxynucleotide derivatives is achieved by an endocytosis mechanism. Uptake is considerably more efficient at low oligomer concentration (less than 1 microM), because at this concentration a significant percentage of the total oligomer pool is absorbed on the cell surface and internalized by a more efficient absorptive endocytosis process. Two modified proteins were detected in mouse fibroblasts that were treated with the alkylating oligonucleotide derivatives. The binding of the oligomers to the proteins is inhibited by other oligodeoxynucleotides, single- and double-stranded DNA, and RNA. The polyanions heparin and chondroitin sulfates A and B do not inhibit binding. These observations suggest the involvement of specific receptor proteins in binding of oligomers to mammalian cells.
Full text
PDF




Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bretscher M. S. Endocytosis: relation to capping and cell locomotion. Science. 1984 May 18;224(4650):681–686. doi: 10.1126/science.6719108. [DOI] [PubMed] [Google Scholar]
- Goldmacher V. S., Tinnel N. L., Nelson B. C. Evidence that pinocytosis in lymphoid cells has a low capacity. J Cell Biol. 1986 Apr;102(4):1312–1319. doi: 10.1083/jcb.102.4.1312. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Harel-Bellan A., Ferris D. K., Vinocour M., Holt J. T., Farrar W. L. Specific inhibition of c-myc protein biosynthesis using an antisense synthetic deoxy-oligonucleotide in human T lymphocytes. J Immunol. 1988 Apr 1;140(7):2431–2435. [PubMed] [Google Scholar]
- Knorre D. G., Vlassov V. V. Complementary-addressed (sequence-specific) modification of nucleic acids. Prog Nucleic Acid Res Mol Biol. 1985;32:291–320. doi: 10.1016/s0079-6603(08)60352-9. [DOI] [PubMed] [Google Scholar]
- Knorre D. G., Vlassov V. V., Zarytova V. F., Karpova G. G. Nucleotide and oligonucleotide derivatives as enzyme and nucleic acid targeted irreversible inhibitors. Chemical aspects. Adv Enzyme Regul. 1985;24:277–299. doi: 10.1016/0065-2571(85)90082-2. [DOI] [PubMed] [Google Scholar]
- Kuppen P. J., Schuitemaker H., van 't Veer L. J., de Bruijn E. A., van Oosterom A. T., Schrier P. I. cis-diamminedichloroplatinum(II)-resistant sublines derived from two human ovarian tumor cell lines. Cancer Res. 1988 Jun 15;48(12):3355–3359. [PubMed] [Google Scholar]
- Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
- Loke S. L., Stein C. A., Zhang X. H., Mori K., Nakanishi M., Subasinghe C., Cohen J. S., Neckers L. M. Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci U S A. 1989 May;86(10):3474–3478. doi: 10.1073/pnas.86.10.3474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller P. S., Ts'o P. O. A new approach to chemotherapy based on molecular biology and nucleic acid chemistry: Matagen (masking tape for gene expression). Anticancer Drug Des. 1987 Oct;2(2):117–128. [PubMed] [Google Scholar]
- Pogodina V. V., Frolova T. V., Abramova T. V., Vlasov V. V., Ivanova E. M. Proizvodnye oligonukleotidov, komplementarnykh virusnoi RNK, ingibiruiut razmnozhenie virusa kleshchevogo éntsefalita v kul'ture kletok. Dokl Akad Nauk SSSR. 1988;301(5):1257–1260. [PubMed] [Google Scholar]
- Roberts A. V., Williams K. E., Lloyd J. B. The pinocytosis of 125I-labelled poly(vinylpyrrolidone), [14C]sucrose and colloidal [198Au]gold by rat yolk sac cultured in vitro. Biochem J. 1977 Nov 15;168(2):239–244. doi: 10.1042/bj1680239. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thilo L. Quantification of endocytosis-derived membrane traffic. Biochim Biophys Acta. 1985 Sep 9;822(2):243–266. doi: 10.1016/0304-4157(85)90010-3. [DOI] [PubMed] [Google Scholar]
- Vlasov V. V., Godovikov A. A., Zarytova V. F., Ivanova E. M., Knorre D. G. Podavlenie sinteza immunoglobulina v kletkakh mielomy MORS 21 alkiliruiushchim proizvodnym oligonukleopeptida, komplentarnogo mRNK, kodiruiushchei legkuiu tsep' immunoglobulina. Dokl Akad Nauk SSSR. 1984;276(5):1263–1265. [PubMed] [Google Scholar]
- Vlassov V. V., Godovikov A. A., Kobetz N. D., Ryte A. S., Yurchenko L. V., Bukrinskaya A. G. Nucleotide and oligonucleotide derivatives as enzyme and nucleic acid targeted irreversible inhibitors. Biochemical aspects. Adv Enzyme Regul. 1985;24:301–320. doi: 10.1016/0065-2571(85)90083-4. [DOI] [PubMed] [Google Scholar]
- Wickstrom E. L., Bacon T. A., Gonzalez A., Freeman D. L., Lyman G. H., Wickstrom E. Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1028–1032. doi: 10.1073/pnas.85.4.1028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zamecnik P. C., Goodchild J., Taguchi Y., Sarin P. S. Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4143–4146. doi: 10.1073/pnas.83.12.4143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zamecnik P. C., Stephenson M. L. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci U S A. 1978 Jan;75(1):280–284. doi: 10.1073/pnas.75.1.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zwerner R. K., Wise K. S., Action R. T. Harvesting the products of cell growth. Methods Enzymol. 1979;58:221–229. doi: 10.1016/s0076-6879(79)58139-7. [DOI] [PubMed] [Google Scholar]